Stephens has recently initiated Inovio Pharmaceuticals Inc (INO) stock to Overweight rating, as announced on May 14, 2024, according to Finviz. Earlier, on January 25, 2024, Oppenheimer had raised the ...

Inovio Pharmaceuticals Inc. closed $12.47 short of its 52-week high ($14.75), which the company reached on April 1st.

Inovio Pharmaceuticals shares are trading higher by 20.7% Tuesday afternoon. Vaccine stocks are rising amid growing concerns ...

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more here.

Inovio Pharmaceuticals Inc. closed $12.93 below its 52-week high ($14.75), which the company achieved on April 1st.

The upside in Precigen's stock comes after it completes the rolling submission of an FDA filing for its first potentially marketed product.

State Street Corp raised its position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) by 11.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 490,662 ...

Inovalis REIT is an intriguing speculative opportunity. It's had a horrible past few years of performance and is now a penny ...

26.79% of the stock is owned by institutional investors. 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever INO has been the ...

Stock market crash today: Infosys, SBI, Tata Steel, Asian Paints, JSW Steel, Bajaj Finserv, Bajaj Finance and Mahindra & Mahindra were the biggest laggards. People look at a screen displaying the ...

Stock Market Today: Domestic equity benchmarks Nifty 50 and Sensex extended losses for the third straight session after investors offloaded utility, capital goods and metal stocks amid foreign ...

The stock has gained ground following similar conference events recently. Positive coverage from Wedbush analyst Daniel Ives has added to the stock's bullish momentum. The stock is gaining ground ...